Low-Molecular-Weight Heparin Benefited Outpatients with High Risk of Venous Thromboembolism Early in COVID-19 PandemicsRiitta Lassila, Markku Mäkijärvi, Mia Wallin et al.|Blood|2024Cited by 1
Early outpatient use of low-molecular-weight heparin benefits COVID-19 outcome in association with hospitalization - Lessons learnedMiika Koskinen, Riitta Lassila, Eeva Ruotsalainen et al.|Thrombosis Research|2025Cited by 0